Letter to the editor submitted in response to ‘Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study’

• Maddalena Napolitano,
• Luca Potestio,
• Francesca Di Vico,
• Gabriella Fabbrocini,
• Cataldo Patruno

Affiliations

Maddalena Napolitano

Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise

Luca Potestio

Section of Dermatology – Department of Clinical Medicine and Surgery, University of Naples, Federico II

Francesca Di Vico

Section of Dermatology – Department of Clinical Medicine and Surgery, University of Naples, Federico II

Gabriella Fabbrocini

Section of Dermatology – Department of Clinical Medicine and Surgery, University of Naples, Federico II

Cataldo Patruno

Department of Health Sciences, University Magna Graecia of Catanzaro